You are here: Industry Insights > Dr. Reddy’s

News List

Dr. Reddy’s receives approval to conduct Phase 3 clinical trial for Sputnik V vaccine in India pharmaceutical-business-review
January 20, 2021
Dr. Reddy’s Laboratories has announced that it has received approval from the Drugs Control General of India (DCGI) to conduct phase 3 clinical trial for the Sputnik V vaccine in India.
Dr. Reddy’s seeks approval from Health Canada for Covid-19 treatment pharmaceutical-technology
December 24, 2020
Dr. Reddy’s Canada has filed an application with Health Canada on behalf of the consortium for Reeqonus (favipiravir) tablets for acute treatment of mild to moderate Covid-19 in adult patients.
Dr. Reddy’s to acquire select anti-allergy brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan pharmaceutical-business-review
December 02, 2020
Dr. Reddy’s Laboratories has entered into a definitive agreement with Glenmark Pharmaceuticals to acquire, subject to completion of certain precedent actions and closing activities, brands Momat Rino (for Russia, Kazakhstan and Uzbekistan) ...
Dr. Reddy’s Announces Third Quarter and Nine Month Fiscal Year 2017 Financial Results americanpharmaceuticalreview
February 08, 2017
Dr. Reddy’s Laboratories has announced its consolidated financial results for the third quarter and nine months ended December 31, 2016 under International Financial Reporting Standards (IFRS).